tradmap

CLOV Clover Health Investments, Corp. /De

$4.32 -3.25%

Data as of close

Financial · Hospital & Medical Service Plans

Clover Health Investments, Corp. /De (CLOV) is a financial company in the Hospital & Medical Service Plans industry, with a market capitalization of $2.3 billion. Shares last traded at $4.32, 22.6% below their 52-week high. Over the past year the stock is up 24.5%. Net profit margin is -3.5%, below the peer median of 1.1%. Revenue grew 40.3% year over year.

Market Cap
$2.3B
Shares Out
531.2M
EPS (TTM)
—
P/E (TTM)*
—
P/S Ratio
0.93
P/B Ratio
6.10
Dividend / Share
—
Dividend Yield
—
52-Week High
$5.58
52-Week Low
$1.58
Volume (venue)
247,274
Avg Vol (3m, venue)
260,625.873

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-5.26%
1M
-1.48%
3M
+1.41%
6M
+63.33%
YTD
+84.22%
1Y
+24.50%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
41.70
SMA (50)
$4.52
SMA (200)
$3.55
Price vs SMA50
-4.34%
Price vs SMA200
+21.63%
ATR (14)
$0.22

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$2.5B
Net Income
-$86M
Gross Margin
10.4%
Operating Margin
-0.7%
Net Margin
-3.5%
Return on Equity
-22.7%
Return on Assets
-11.9%
Current Ratio
1.50
Debt / Equity
0.00
Revenue Growth (YoY)
+40.3%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $0.05 2026-08-07
Q1 2026 $0.05 2026-05-08
Q2 2025 -$0.02 —
Q1 2025 $0.00 —
Q4 2023 (derived) -$0.14 2024-03-14
FY 2023 -$0.44 2024-03-14

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Hospital & Medical Service Plans peers

CLOV vs 10 industry peers (Hospital & Medical Service Plans), by market cap. Data as of close

P/S vs peers
0.93 / 0.40 med
+131% premium
Net margin vs peers
-3.5% / 1.1% med
below median
1–10 of 10
UNHUnitedHealth Group$359.4B25.450.803.1%-1.54%
ELVElevance Health$89.4B17.390.442.5%-1.47%
CICigna$78.0B13.090.282.1%-1.03%
HUMHumana$49.3B43.590.360.8%-0.97%
CNCCentene Corporation$32.9B22.560.180.8%-2.80%
MOHMolina Healthcare, Inc.$10.9B—0.25-0.1%+1.88%
OSCROscar Health, Inc.$9.6B17.370.824.7%+2.11%
CLOVClover Health Investments, Corp. /De$2.3B—0.93-3.5%-3.25%
ALHCAlignment Healthcare, Inc.$1.5B50.480.300.6%-4.32%
TRUPTrupanion, Inc.$1.4B69.490.891.3%+1.99%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.